Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter
Access to hospital-based eye care and reimbursement were policy topics at the…
Phase 2 data for kamuvudine K8, an investigational inflammasome-directed treatment from Inflammasome…
Two transactions announced in September and October 2026 show capital moving through…
GenSight Biologics and the Quinze-Vingts National Ophthalmology Hospital in Paris announced on…
Stephen Tsang, MD, PhD, professor at Columbia University and attending physician at…
In celebration of Ophthalmology Times’ 50th anniversary, we invited leaders in ophthalmology…
(Image Credit: AdobeStock) Luis Arias, MD; and Paolo Lanzetta, MD, recently found…
A novel topical, incision-free therapy is now approved to help ophthalmologists slow…
(Image Credit: AdobeStock) The intracanalicular dexamethasone ophthalmic insert (Dextenza; Ocular Therapeutix) incorporates…
(Image Credit: AdobeStock) Dompé was selected by the US Food and Drug…
Note: Video captions are generated with the assistance of AI and may…
Note: Video captions are generated with the assistance of AI and may…
(Image Credit: AdobeStock) Stoke Therapeutics announced 2-year data from the FALCON study,…
Enter your email address below and subscribe to our newsletter